Piowin G 1mg/500mg/15mg Tablet SR
Marketer
Serwina Pharmaceuticals Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Piowin G 1mg/500mg/15mg Tablet SR
Gliclazide, metformin, and pioglitazone (1mg/500mg/15mg SR) tablets offer a combined approach to managing elevated blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, leading to reduced blood sugar. Dosage and frequency should strictly follow your physician's instructions. Taking this medication with food minimizes stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol consumption, or meal skipping increases the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should consult their physician before using this medication. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption due to the potential for increased side effects.
Uses of Piowin G 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Piowin G 1mg/500mg/15mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Piowin G 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Piowin G 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Piowin G 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Piowin G 1mg/500mg/15mg Extended-Release tablets with a meal.
How Piowin G 1mg/500mg/15mg Tablet SR works:
Piowin G SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Piowin G 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Piowin G 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Piowin G 1mg/500mg/15mg tablets are likely not safe for use while breastfeeding. Preliminary evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Piowin G 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Piowin G 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. The use of Piowin G 1mg/500mg/15mg SR tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Piowin G 1mg/500mg/15mg Tablet SR :
Should you forget to take your Piowin G 1mg/500mg/15mg SR Tablet, administer it immediately upon remembering. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Piowin G 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently